In vitro evaluation of concurrent use of commercially available insect repellent and sunscreen preparations

British Journal of Dermatology

Volumn 152, Issue 6, 2005, Pages 1263-1267

  Gu, Xiaochen ^a   Wang, T ^a   Collins, D M ^a   Kasichayanula, S ^a   Burczynski, F J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Concurrent use; In vitro diffusion; Insect repellent; Sunscreen

Indexed keywords

DIETHYLTOLUAMIDE; INSECT REPELLENT; NON PRESCRIPTION DRUG; OXYBENZONE; SUNSCREEN;

AEROSOL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DRUG ABSORPTION; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG PENETRATION; DRUG POTENTIATION; DRUG UTILIZATION; EVALUATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LOTION; NONHUMAN; PRIORITY JOURNAL; SKIN CANCER; SKIN PENETRATION; SKIN PERMEABILITY; SWINE; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ADMINISTRATION, TOPICAL; ANIMALS; BENZOPHENONES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEET; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; DRUGS, NON-PRESCRIPTION; INSECT REPELLENTS; MODELS, ANIMAL; SKIN ABSORPTION; SUNSCREENING AGENTS; SWINE;

EID: 21644457504     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06691.x     Document Type: Article

References (26)

1. Fradin MS, Day JF. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med 2002; 347:13-18.
2. Staub D, Debrunner M, Amsler L, Steffen R. Effectiveness of a repellent containing DEET and EBAAP for preventing tick bites. Wilderness Environ Med 2002; 13:12-20.
3. Dennis LK, Beane-Freeman LE, VanBeek MJ. Sunscreen use and the risk for melanoma: a quantitative review. Ann Intern Med 2003; 139:966-78.
4. Cokkinides VE, Weinstock MA, Cardinez CJ, O'Connel MA. Sunsafe practices in U.S. youth and their parents: role of caregiver on youth sunscreen use. Am J Prev Med 2004; 26:147-51.
5. Smith CN, Gilbert IH, Gouck HK et al. Factors affecting the protection period of mosquito repellents. USDA Tech Bull 1963; no. 1285.
6. Feldmann RJ, Maibach HI. Absorption of some organic compounds through the skin in man. J Invest Dermatol 1970; 54:399-404.
7. Spencer TS, Hill JA, Feldmann RJ, Maibach HI. Evaporation of diethyltoluamide from human skin in vivo and in vitro. J Invest Dermatol 1979; 72:317-19.
8. Brand RM, Spalding M, Mueller C. Sunscreen can increase dermal penetration of 2,4-dichlorophenoxyacetic acid. J Toxicol 2002; 40:827-32.
9. Montemarano AD, Gupta RK, Burge JR, Klein K. Insect repellents and the efficacy of sunscreen. Lancet 1997; 349:1670-1.
10. Murphy ME, Montemarano AD, Debboun M, Gupta R. The effect of sunscreen on the efficacy of insect repellent: a clinical trial. J Am Acad Dermatol 2000; 43:219-22.
11. Gu X, Kasichayanula S, Fediuk DJ, Burczynski FJ. In vitro permeation of the insect repellent N,N-diethyl-m-toluamide (DEET) and the sunscreen oxybenzone. J Pharm Pharmacol 2004; 56:621-8.
12. Lazar GM, Baillet A, Fructus AE et al. Evaluation of in vitro percutaneous absorption of UV filters used in sunscreen formulations. Drug Cosmet Ind 1996; 158:50-62.
13. Gupta VK, Zatz JL, Rerek M. Percutaneous absorption of sunscreen through micro-yucatan pig skin in vitro. Pharm Res 1999; 16:1602-7.
14. Koren G, Matsui D, Bailey B. DEET-based insect repellents: safety implications for children and pregnant and lactating women. Can Med Assoc J 2003; 169:209-12.
15. Centers for Disease Control and Prevention. Insect Repellent Use and Safety. http://www.cdc.gov/ncidod/dvbid/westnile/qa/insect_ repellent.htm (accessed 08/10/04).
16. Health Canada Pest Management Regulatory Agency Regulatory Note. Personal Insect Repellent and Sunscreen Combinations (REG2000-07). http://www.pmra-arla. gc.ca/english/pdf/reg/reg2000-07-e.pdf (accessed 08/10/04).
17. Salafsky B, Ramaswamy K, He Y et al. Development and evaluation of LipoDEET, a new long-acting formulation of N,N-diethyl-m-toluamide (DEET) for the prevention of schistosomiasis. Am J Trop Med Hyg 1999; 61:743-50.
18. Ross JS, Shah JC. Reduction in skin permeation of N,N-diethyl-m-toluamide (DEET) by altering the skin/vehicle partition coefficient. J Control Release 2000; 67:111-11.
19. Woolfson AD, Malcolm RK, Campbell K et al. Rheological, mechanical and membrane penetration properties of novel dual drug systems for percutaneous delivery. J Control Release 2000; 67:395-408.
20. Miller JD. Anaphylaxis associated with insect repellent. N Engl J Med 1982; 307:1341-2.
21. Baynes RE, Hailing KB, Riviere JE. The influence of diethyl-m-toluamide (DEET) on the percutaneous absorption of permethrin and carbaryl. Toxicol Appl Pharmacol 1997; 144:332-9.
22. Fradin MS. Mosquitoes and mosquito repellents: a clinician's guide. Ann Intern Med 1998; 128:931-40.
23. Briassoulis G, Narlioglou M, Hatzis T. Toxic encephalopathy associated with use of DEET insect repellents: a case analysis of its toxicity in children. Hum Exp Toxicol 2001; 20:8-14.
24. Chaney LA, Rockhold RW, Hume AS. Cardiorespiratory effects following acute exposure to pyridostigmine bromide and/or N,N-diethyl-m-toluamide (DEET) in rats. Int J Toxicol 2002; 21:287-300.
25. Hayden CJ, Roberts MS, Benson HAE. Systemic absorption of sunscreen after topical application. Lancet 1997; 350:863-4.
26. Nohynek GJ, Schaefer H. Benefit and risk of organic ultraviolet filters. Regul Toxicol Pharmacol 2001; 33:285-99.